Dave Mullarkey

Salesforce ExactTarget Outlook Pardot

biotechnology research liquid biopsy early cancer detection pancreatic cancer tests ovarian cancer tests epigenomics platform cell-free dna analysis biomarker analysis 5-hydroxymethylcytosine cancer screening multi-cancer panels non-invasive cancer detection blood-based assays cancer diagnosis cancer therapy monitoring clinical trials machine learning algorithms biopharma services patient care innovation high-mortality cancers clinical evidence high-risk patients diagnostic precision tumor biology comprehension patient outcomes research & development fda breakthrough device epigenomic signals patient-centric solutions cancer recurrence detection standard blood draw healthcare partnerships molecular diagnostics oncology advancements risk stratification biological changes in cells innovative detection methods epigenomic changes monitoring diagnostic test development clinical validation health policy strategies patient-focused services therapeutic response monitoring next-generation sequencing biological markers cancer treatment options diagnostic accuracy genomic medicine therapeutic selection support ectopic tissue monitoring health care health wellness & fitness hospital & health care